HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,775 | +5.9% | 6,303 | 0.0% | 0.01% | +12.5% |
| Q2 2023 | $227,349 | -13.2% | 6,303 | -8.1% | 0.01% | -27.3% |
| Q1 2023 | $262,060 | -32.9% | 6,862 | 0.0% | 0.01% | -73.2% |
| Q4 2022 | $390,448 | +35.6% | 6,862 | -5.7% | 0.04% | +192.9% |
| Q3 2022 | $288,000 | -10.0% | 7,274 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $320,000 | +10.3% | 7,274 | 0.0% | 0.01% | +27.3% |
| Q1 2022 | $290,000 | -0.7% | 7,274 | 0.0% | 0.01% | +10.0% |
| Q4 2021 | $292,000 | -1.4% | 7,274 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $296,000 | -10.3% | 7,274 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $330,000 | +8.9% | 7,274 | 0.0% | 0.01% | +9.1% |
| Q1 2021 | $303,000 | -2.6% | 7,274 | 0.0% | 0.01% | -21.4% |
| Q4 2020 | $311,000 | – | 7,274 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |